XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income
Total
Balance at Dec. 31, 2022 $ 30 $ 229 $ 172,471 $ 316,279 $ 15,761 $ 504,770
Balance at Mar. 31, 2023 30 227 167,436 300,066 10,870 478,629
Balance at Dec. 31, 2022 30 229 172,471 316,279 15,761 504,770
Increase (decrease) in shareholders' equity            
Net Income (Loss) Attributable to the Company       (4,193)   (4,193)
Stock Repurchase   (3) (5,082)     (5,085)
Vested Restricted Stock and Performance Shares   1 (1,029)     (1,028)
Exercise of Stock Options and Stock Issuance to Directors     241     241
Payment of Equity Issuance Costs     (122)     (122)
Stock-Based Compensation Expense     1,624     1,624
Preferred Stock Dividends Declared for the Period       (2,390)   (2,390)
Common Stock Dividends Declared for the Period       (17,738)   (17,738)
Other Comprehensive Income         2,488 2,488
Balance at Jun. 30, 2023 30 227 168,103 291,958 18,249 478,567
Balance at Mar. 31, 2023 30 227 167,436 300,066 10,870 478,629
Increase (decrease) in shareholders' equity            
Net Income (Loss) Attributable to the Company       1,800   1,800
Stock Repurchase     (76)     (76)
Payment of Equity Issuance Costs     (51)     (51)
Stock-Based Compensation Expense     794     794
Preferred Stock Dividends Declared for the Period       (1,195)   (1,195)
Common Stock Dividends Declared for the Period       (8,713)   (8,713)
Other Comprehensive Income         7,379 7,379
Balance at Jun. 30, 2023 30 227 168,103 291,958 18,249 478,567
Balance at Dec. 31, 2023 30 226 168,435 281,944 6,891 457,526
Increase (decrease) in shareholders' equity            
Net Income (Loss) Attributable to the Company       7,025   7,025
Stock Repurchase     (664)     (664)
Vested Restricted Stock and Performance Shares   1 (1,275)     (1,274)
Issuance of Preferred Stock, Net of Underwriting Discount and Expenses 17   32,979     32,996
Exercise of Stock Options and Stock Issuance to Directors     469     469
Stock Issuance, Net of Equity Issuance Costs   4 6,292     6,296
Stock-Based Compensation Expense     1,646     1,646
Preferred Stock Dividends Declared for the Period       (3,058)   (3,058)
Common Stock Dividends Declared for the Period       (17,642)   (17,642)
Other Comprehensive Income         8,495 8,495
Balance at Jun. 30, 2024 47 231 207,882 268,269 15,386 491,815
Balance at Mar. 31, 2024 30 229 169,924 277,654 14,404 462,241
Increase (decrease) in shareholders' equity            
Net Income (Loss) Attributable to the Company       1,183   1,183
Issuance of Preferred Stock, Net of Underwriting Discount and Expenses 17   32,979     32,996
Exercise of Stock Options and Stock Issuance to Directors     89     89
Stock Issuance, Net of Equity Issuance Costs   2 4,230     4,232
Stock-Based Compensation Expense     660     660
Preferred Stock Dividends Declared for the Period       (1,871)   (1,871)
Common Stock Dividends Declared for the Period       (8,697)   (8,697)
Other Comprehensive Income         982 982
Balance at Jun. 30, 2024 $ 47 $ 231 $ 207,882 $ 268,269 $ 15,386 $ 491,815